Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 430

Results For "IT"

10487 News Found

SIMPACT 2026 convenes India’s healthcare leaders to advance simulation-driven education
Healthcare | April 06, 2026

SIMPACT 2026 convenes India’s healthcare leaders to advance simulation-driven education

Participants also experienced a VR-enabled learning environment designed to support clinical skill development in controlled, repeatable, and risk-free settings


AstraZeneca, Roche-backed study supports risk-based HF screening in diabetes
Healthcare | April 06, 2026

AstraZeneca, Roche-backed study supports risk-based HF screening in diabetes

Researchers say simple blood-test and echocardiography pathway could reshape diabetes-related cardiovascular care


Enveric Biosciences bags key US patent for mental health drug
Biotech | April 06, 2026

Enveric Biosciences bags key US patent for mental health drug

EB-003 is Enveric’s lead neuroplastogen, a 5-HT2A / 5-HT1B dual-acting compound designed to promote neuroplastic changes


Dr Reddy’s elevates Saran PS as Head of Launch Excellence and Program Management
People | April 06, 2026

Dr Reddy’s elevates Saran PS as Head of Launch Excellence and Program Management

In his new role, Saran will spearhead the end-to-end launch framework for innovation-led portfolio


Experts advocate holistic Semaglutide use as therapy goes off patent in India
Healthcare | April 06, 2026

Experts advocate holistic Semaglutide use as therapy goes off patent in India

They also differentiated the innovator biologic Semaglutide molecule from newer synthetic or chemical generic versions entering the market


AstraZeneca combo therapy shows breakthrough in liver cancer trial
Clinical Trials | April 05, 2026

AstraZeneca combo therapy shows breakthrough in liver cancer trial

The study met its primary endpoint, showing a statistically significant and clinically meaningful improvement in progression-free survival


Innovent Biologics’ OLN324 shows breakthrough results in vision disease study
Biopharma | April 05, 2026

Innovent Biologics’ OLN324 shows breakthrough results in vision disease study

The JADE trial enrolled 164 U.S. patients who initially received three monthly doses of OLN324 or faricimab, followed by 12 weeks off treatment with retreatment allowed only if disease recurred


Sun Pharma appoints former PwC India COO Satyavati Berera as independent director
Appointment | April 05, 2026

Sun Pharma appoints former PwC India COO Satyavati Berera as independent director

Board approves five-year appointment, subject to shareholder nod through postal ballot


Concord Biotech acquires Celliimune to accelerate DNA-engineered cancer therapies
Biotech | April 04, 2026

Concord Biotech acquires Celliimune to accelerate DNA-engineered cancer therapies

Rs 66 lakh acquisition will support DNA engineering and novel cell-gene therapy alternatives to conventional chemotherapy